We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Saturday, April 12, 2025
A new licensing agreement between three parties will allow CRISPR-Cas9 and similar gene editing tools to be used to produce camelina varieties for biofuel advancement.
